Andrew C. Jackson - Net Worth and Insider Trading

Andrew C. Jackson Net Worth

The estimated net worth of Andrew C. Jackson is at least $242 dollars as of 2024-05-26. Andrew C. Jackson is the CFO of Catheter Precision Inc and owns about 461 shares of Catheter Precision Inc (VTAK) stock worth over $242. Details can be seen in Andrew C. Jackson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Andrew C. Jackson has not made any transactions after 2021-11-22 and currently still holds the listed stock(s).

Transaction Summary of Andrew C. Jackson

Andrew C. Jackson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Andrew C. Jackson owns 4 companies in total, including Catheter Precision Inc (VTAK) , Eiger BioPharmaceuticals Inc (EIGRQ) , and Eterna Therapeutics Inc (ERNA) among others .

Click here to see the complete history of Andrew C. Jackson’s form 4 insider trades.

Insider Ownership Summary of Andrew C. Jackson

Ticker	Comapny	Transaction Date	Type of Owner
VTAK	Catheter Precision Inc	2021-11-22	CFO & Secretary
EIGRQ	Eiger BioPharmaceuticals Inc	2015-03-11	See Remarks
ERNA	Eterna Therapeutics Inc	2022-05-31	Chief Financial Officer
		2023-10-30	Chief Financial Officer

Andrew C. Jackson Latest Holdings Summary

Andrew C. Jackson currently owns a total of 1 stock. Andrew C. Jackson owns 461 shares of Catheter Precision Inc (VTAK) as of November 22, 2021, with a value of $242.

Latest Holdings of Andrew C. Jackson

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
VTAK	Catheter Precision Inc	2021-11-22	461	0.53	242

Holding Weightings of Andrew C. Jackson

Andrew C. Jackson Form 4 Trading Tracker

According to the SEC Form 4 filings, Andrew C. Jackson has made a total of 4 transactions in Catheter Precision Inc (VTAK) over the past 5 years, including 2 buys and 2 sells. The most-recent trade in Catheter Precision Inc is the sale of 54 shares on November 22, 2021, which brought Andrew C. Jackson around $7,032.

Insider Trading History of Andrew C. Jackson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Andrew C. Jackson Trading Performance

GuruFocus tracks the stock performance after each of Andrew C. Jackson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew C. Jackson is -31.45%. GuruFocus also compares Andrew C. Jackson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew C. Jackson within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Andrew C. Jackson's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Andrew C. Jackson

Average Return

Average return per transaction

Outperforming Transactions

0 out of 2 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	7.34
Relative Return to S&P 500(%)	2.15

Andrew C. Jackson Ownership Network

Ownership Network List of Andrew C. Jackson

No Data

Ownership Network Relation of Andrew C. Jackson

Andrew C. Jackson Owned Company Details

What does Catheter Precision Inc do?

Who are the key executives at Catheter Precision Inc?

Andrew C. Jackson is the CFO & Secretary of Catheter Precision Inc. Other key executives at Catheter Precision Inc include director & Executive Chairman of Board David A Jenkins , Chief Financial Officer Steven K Passey , and Chief Financial Officer Brian Conn .

Catheter Precision Inc (VTAK) Insider Trades Summary

Over the past 18 months, Andrew C. Jackson made no insider transaction in Catheter Precision Inc (VTAK). Other recent insider transactions involving Catheter Precision Inc (VTAK) include a net purchase of 52,259 shares made by David A Jenkins ,

In summary, during the past 3 months, insiders sold 0 shares of Catheter Precision Inc (VTAK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Catheter Precision Inc (VTAK) were sold and 52,259 shares were bought by its insiders, resulting in a net purchase of 52,259 shares.

Catheter Precision Inc (VTAK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Catheter Precision Inc Insider Transactions

No Available Data

What does Eiger BioPharmaceuticals Inc do?

Who are the key executives at Eiger BioPharmaceuticals Inc?

Andrew C. Jackson is the See Remarks of Eiger BioPharmaceuticals Inc. Other key executives at Eiger BioPharmaceuticals Inc include 10 percent owner Richard A Kayne , 10 percent owner Leen Kawas , and Chief Business Officer Ingrid Choong .

Eiger BioPharmaceuticals Inc (EIGRQ) Insider Trades Summary

Over the past 18 months, Andrew C. Jackson made no insider transaction in Eiger BioPharmaceuticals Inc (EIGRQ). Other recent insider transactions involving Eiger BioPharmaceuticals Inc (EIGRQ) include a net purchase of 27,500 shares made by Thomas John Dietz , a net purchase of 278,239 shares made by Richard A Kayne , and a net purchase of 100,000 shares made by Jeffrey S Glenn .

In summary, during the past 3 months, insiders sold 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 896 shares of Eiger BioPharmaceuticals Inc (EIGRQ) were sold and 15,086 shares were bought by its insiders, resulting in a net purchase of 14,189 shares.

Eiger BioPharmaceuticals Inc (EIGRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Eiger BioPharmaceuticals Inc Insider Transactions

No Available Data

What does Eterna Therapeutics Inc do?

Who are the key executives at Eterna Therapeutics Inc?

Andrew C. Jackson is the Chief Financial Officer of Eterna Therapeutics Inc. Other key executives at Eterna Therapeutics Inc include 10 percent owner Charles Cherington , 10 percent owner Freebird Investments Llc , and 10 percent owner Freebird Partners Lp .

Eterna Therapeutics Inc (ERNA) Insider Trades Summary

Over the past 18 months, Andrew C. Jackson made no insider transaction in Eterna Therapeutics Inc (ERNA). Other recent insider transactions involving Eterna Therapeutics Inc (ERNA) include a net purchase of 335,920 shares made by John D Halpern , a net purchase of 283,286 shares made by Nicholas Jason Singer , and a net purchase of 261,756 shares made by Charles Cherington .

In summary, during the past 3 months, insiders sold 0 shares of Eterna Therapeutics Inc (ERNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eterna Therapeutics Inc (ERNA) were sold and 880,962 shares were bought by its insiders, resulting in a net purchase of 880,962 shares.

Eterna Therapeutics Inc (ERNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Eterna Therapeutics Inc Insider Transactions

No Available Data

What does First Light Acquisition Group Inc do?

Who are the key executives at First Light Acquisition Group Inc?

Andrew C. Jackson is the Chief Financial Officer of First Light Acquisition Group Inc. Other key executives at First Light Acquisition Group Inc include VP of Technical Operations Amish Patel , 10 percent owner Ajc Capital, Llc , and 10 percent owner Jamir Trust .

First Light Acquisition Group Inc (FLAG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of First Light Acquisition Group Inc (FLAG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of First Light Acquisition Group Inc (FLAG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

First Light Acquisition Group Inc (FLAG)'s detailed insider trading history can be found in Insider Trading Tracker table.

First Light Acquisition Group Inc Insider Transactions

No Available Data

Andrew C. Jackson Mailing Address

Above is the net worth, insider trading, and ownership report for Andrew C. Jackson. You might contact Andrew C. Jackson via mailing address: 11988 El Camino Real Ste. 650, San Diego Ca 92130.

Discussions on Andrew C. Jackson

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.